ALNY vs TWFG · P/E 76, rev $1.29B vs P/E 37, rev $248.5M
Alnylam Pharmaceuticals Inc (ALNY) versus TWFG, Inc. Class A Common Stock (TWFG) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
TWFG, Inc. Class A Common Stock (TWFG) is a insurance brokers company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported TWFG revenue for 2025-12-31 was $248.5M. Net income was $41.2M. Revenue was up 22.0% from 2024-12-31 to 2025-12-31. TWFG currently screens at market cap $272.5M and trailing P/E 37.4.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. TWFG currently screens at market cap $272.5M and trailing P/E 37.4.
Not investment advice. Open the ALNY and TWFG stock pages for the full models.
Not investment advice.